NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism - Summary - MDSpire

NLRP12 in cancer: a context-dependent regulator of tumor progression, immunity, and metabolism

  • By

  • Yuting Cen

  • Li Li

  • Xinyu Ding

  • Chenyang Wang

  • Hua Qiu

  • July 10, 2026

  • 0 min

Share

Objective:

To summarize the molecular and functional landscape of NLRP12 in cancer, emphasizing its dual roles in tumor biology and context-specific mechanisms.

Approach:
  • Contextual Analysis: Review of NLRP12's functions across various malignancies, highlighting its role as both a tumor suppressor and promoter.
Key Findings:
  • NLRP12 exhibits context-dependent roles in cancer, acting as a tumor suppressor in some malignancies and a tumor promoter in others.
  • In inflammation-associated cancers, NLRP12 suppresses tumor progression by inhibiting noncanonical NF-κB, Wnt/β-catenin, and JNK signaling.
  • In gastric cancer, ovarian cancer, and glioma, NLRP12 is linked to glycolytic remodeling, lactate-associated epigenetic adaptation, aggressive clinicopathological features, and immune suppression.
Interpretation:

NLRP12 is a multifunctional signaling regulator that connects inflammatory control with oncogenic pathways, metabolism, and immune responses.

Limitations:
  • The complexity of NLRP12's roles necessitates further studies to fully understand its context-dependent functions in various tumor microenvironments.
Conclusion:

NLRP12's role may be redefined from a conventional innate immune regulator to a context-dependent organizer of tumor ecosystems.

Original Source(s)

Related Content